Xeris Biopharma Holdings (XERS) Total Debt Growth (3y) (2026)

Xeris Biopharma Holdings (XERS) Total Debt Growth (3y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn -7.03%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.29%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -58.89%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn -
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -12.80%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 72.82%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -4.66%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Xeris Biopharma Holdings 1.07 Bn 954.87 Mn 72.55 Mn 145.46%

Historic Data

Download Data
DateValue
Mar 31, 2026 145.46%